Related by context. All words. (Click for frequent words.) 77 randomized controlled trials 76 meta analyzes 73 randomized trials 72 observational studies 70 randomized clinical trials 69 observational study 68 epidemiologic studies 68 randomized controlled trial 68 epidemiological studies 65 RCTs 64 multicenter study 64 NEJM 64 randomized clinical 64 metaanalysis 64 prospective cohort 63 Cochrane Systematic Review 63 randomized controlled clinical trials 63 placebo controlled trials 62 placebo controlled studies 62 subgroup analyzes 61 randomized controlled trials RCTs 61 randomized controlled 61 longitudinal study 61 nonrandomized 61 Cochrane Database 61 retrospective cohort study 61 trials RCTs 60 multicenter 60 meta regression 60 substudy 60 calcium supplementation 60 retrospective cohort 60 Meta analyzes 60 Observational studies 59 longitudinal studies 59 RE LY 59 heartwire 59 prospective observational 59 study 59 Diabetologia 59 post hoc 58 JAMA 58 randomized placebo controlled 58 Systematic Reviews 58 ALLHAT 58 journal Lancet Neurology 58 placebo controlled 58 Subgroup analyzes 58 prospective randomized controlled 58 multicentre 58 prospective observational studies 58 RE LY trial 57 postmenopausal women 57 INTERHEART study 57 Clinical Antipsychotic Trials 57 Health Initiative WHI 57 meta analytic 57 MADIT CRT trial 57 Cochrane Library 57 journal Ophthalmology 57 Lancet 57 randomized controlled clinical 57 prospective randomized 57 ExTRACT TIMI 57 Lancet Neurology 57 Intervention Effectiveness CATIE 57 NICE SUGAR 57 placebo controlled clinical 57 Clinical Psychiatry 56 ConclusionThis 56 subanalysis 56 longitudinal cohort study 56 RE LY ® 56 Framingham Offspring Study 56 selenium supplementation 56 multivariate analyzes 56 Intervention Trial GAIT 56 multicenter trials 56 BJU International 56 retrospective observational study 56 periprocedural MI 56 prospective longitudinal 56 journal Atherosclerosis 56 Cochrane reviewers 56 NHANES III 56 epidemiologic 56 postmenopausal hormone therapy 56 Intervention Effectiveness 56 antioxidant supplements 56 Prostate Cancer Prevention 56 journal Psychotherapy 56 rosiglitazone 56 vitamin D supplementation 56 tibolone 55 HCV SPRINT 55 Carotid Revascularization Endarterectomy vs. 55 lipid lowering therapy 55 generalizability 55 beta carotene supplementation 55 AVERROES 55 liver transplant recipients 55 statins 55 PROactive study 55 WHI 55 Subgroup analysis 55 journal Clinical Gastroenterology 55 CALGB 55 CARE HF 55 Medicine NEJM 55 Cholesterol Levels SPARCL 55 vitro studies 55 statin 55 Intervention Trial 55 Psychosomatic Medicine 55 genomewide association study 55 BARI 2D 55 correlational 55 meta analysis pooling 55 multicentre study 55 logistic regression analyzes 55 Aggressive Reduction 55 HORIZONS AMI trial 55 Nissen meta analysis 55 SPARCL 54 multicenter randomized 54 Atherosclerosis MESA 54 cardiovascular mortality 54 NHANES 54 ACUITY trial 54 Communities ARIC study 54 journal Lancet Oncology 54 QRISK 54 Clinical Gastroenterology 54 Observational Study 54 randomized 54 ezetimibe simvastatin 54 journal Epidemiology 54 Multi Ethnic Study 54 statin therapy 54 BMC Psychiatry 54 univariate 54 dyslipidaemia 54 #F FDG PET 54 dietary questionnaires 54 Edge STudy 54 General Psychiatry 54 Reynolds Risk Score 54 folic acid supplementation 54 clinicopathological 54 prospective observational cohort 54 logistic regression analysis 54 dietary intakes 54 Meta Analysis 54 SABCS 54 Randomized trials 54 Chicago Multidisciplinary Symposium 54 BOLDER II 54 methodologic 54 UKPDS 54 APPROVe 54 journal Gastroenterology 54 Wactawski Wende 54 IQWiG 54 Systematic Review 53 nesiritide 53 Lancet Oncology 53 serum cholesterol 53 & Rheumatism 53 genetic variants 53 phase IIIb 53 studies 53 Dtsch Arztebl Int 53 Clinical Nutrition 53 immunohistochemical staining 53 homocysteine concentrations 53 thiazide diuretics 53 journal Biological Psychiatry 53 dietary intake 53 postoperative mortality 53 genetic polymorphisms 53 Lipid Lowering Treatment 53 journal Neurology 53 randomized multicenter 53 prospective nonrandomized 53 pre menopausal 53 HYVET 53 Digital Mammographic Imaging 53 nonfatal MI 53 coinvestigators 53 clinical trial 53 RECORD1 53 Laryngoscope 53 Multiethnic Study 53 J Clin Oncol 53 AIM HIGH 53 Schizophrenia Bulletin 53 Evaluation WISE 53 cardioprotective effects 53 chest radiographs 53 randomized multicenter trial 53 journal Contraception 53 PLCO 53 epidemiological 53 journal Urology 53 STEP BD 53 IMPROVE HF 53 multicenter placebo controlled 53 ACOSOG Z# 53 RIO Lipids 53 ONTARGET 53 colorectal adenoma 53 fluvastatin 53 ATACAND 53 Vitamin D supplementation 53 reboxetine 53 folate supplementation 53 DMIST 53 pharmacoeconomic analysis 53 Neuropsychologia 53 Stenting Trial CREST 53 F FDG PET 53 myocardial infarctions MIs 53 VADT 53 regression analyzes 53 SORT OUT III 53 Lancet Neurology journal 52 genomewide 52 Thorax 52 neuroimaging studies 52 nonrandomized studies 52 Maturitas 52 mammographic density 52 elevated CRP 52 multicentre randomized 52 PLCO trial 52 metabolic parameters 52 #:#-# [031] 52 prospective multicentre 52 oral diclofenac 52 EURIDIS 52 pharmacokinetic PK 52 colorectal adenomas 52 CAMMS# 52 postmenopausal breast cancer 52 colorectal neoplasia 52 Prospective Investigation 52 journal Appetite 52 journal Stroke 52 chemoprevention trials 52 journal Hepatology 52 HF ACTION 52 journal Resuscitation 52 idraparinux 52 journal Circulation Cardiovascular 52 Arch Neurol 52 CANCER peer reviewed 52 cardiovascular morbidity 52 atherothrombotic disease 52 MADIT II 52 Staessen 52 #-# Full Text 52 locoregional recurrence 52 double blinded randomized 52 genomewide association studies 52 MERLIN TIMI 52 myocardial infarctions 52 randomized Phase III 52 EVEREST II 52 rosuvastatin Crestor 52 paclitaxel eluting stents 52 comorbidity 52 BMC Musculoskeletal Disorders 52 journal Rheumatology 52 nomogram 52 Arch Surg 52 randomized double 52 morphometric vertebral fractures 52 Netherlands Cohort Study 52 hormone therapy estrogen 52 ECASS 52 Multiple logistic regression 52 Internal Medicine 52 journal Sleep 52 prospectively defined 52 Diabetic Medicine 52 Screening Trial DMIST 52 observational cohort study 52 Vauthey 52 subclinical atherosclerosis 52 beta blocker therapy 52 β blockers 52 journal Anesthesiology 52 infantile colic 52 Francesca Bravi 52 valsartan 52 aldosterone antagonist 52 NeuroImage 52 chromium supplementation 52 conditional logistic regression 52 Randomized controlled 52 journal Pharmacoepidemiology 52 ximelagatran 52 ACCORD Lipid 52 journal Gut 52 multiple logistic regression 52 placebo controlled clinical trials 52 Wisconsin Sleep Cohort 52 GIK infusion 52 antioxidant supplementation 52 #:#-# [029] 52 residual confounding 52 journal Hypertension 52 Arch Intern Med 52 journal Menopause 52 Prostate Lung Colorectal 52 Interphone study 52 journal Psychosomatic Medicine 52 pegylated liposomal doxorubicin 52 SGAs 52 Aggressive Drug Evaluation 52 journal Obesity 51 Univariate 51 ENDEAVOR clinical 51 BMJ 51 Screening Trial 51 multivariate regression analysis 51 HeFT 51 estrogen progestin therapy 51 rosuvastatin 51 hypercholesterolemia 51 TRITON TIMI 51 cerebral microbleeds 51 KRAS variant 51 Ascherio 51 Pharmacotherapy 51 Lp PLA2 51 psychodynamic psychotherapy 51 adenoma recurrence 51 HOPE TOO 51 FDG PET 51 generalisability 51 nondiabetic patients 51 Vertos II 51 Molecular Psychiatry 51 Clinical Endocrinology & 51 Univariate analysis 51 Am J Cardiol 51 macrovascular disease 51 cilostazol 51 perimenopausal women 51 SCD HeFT 51 strontium ranelate 51 folate intake 51 Dietary Modification Trial 51 randomized blinded 51 CARDIA 51 APPRAISE 51 Lancet Infectious Diseases 51 Conclusions 51 multicenter randomized clinical 51 blind randomized 51 ginkgo biloba extract 51 intensive statin therapy 51 antitumor effect 51 Kaplan Meier analysis 51 STRIDE PD 51 Clinical Endocrinology 51 genetic variants associated 51 homocysteine lowering 51 glitazones 51 Acta Paediatrica 51 Affective Disorders 51 journal Molecular Psychiatry 51 multicenter randomized controlled 51 SPIRIT III 51 dietary modification 51 lipid lowering drugs 51 SPIRIT IV 51 candesartan 51 antiplatelet agents 51 journal Cerebral Cortex 51 eprotirome 51 undergone radical prostatectomy 51 Women Ischemia Syndrome 51 Psychological Bulletin 51 PLoS Medicine 51 NNRTI resistance 51 acrylamide intake 51 Edward Giovannucci 51 journal Neuropsychology 51 interobserver 51 testosterone supplementation 51 univariate analyzes 51 immunohistochemical 51 androgen suppression 51 meta analytic review 51 Longitudinal Study 51 riociguat 51 journal Circulation 51 NCCTG N# 51 hydroxyvitamin D levels 51 covariate 51 blinded randomized controlled 51 dabigatran 51 Deutsches Arzteblatt International 51 CYPHER R Sirolimus eluting 51 prucalopride 51 GISSI HF 51 atorvastatin Lipitor 51 homocysteine levels 51 PCI ExTRACT TIMI 51 TAXUS IV 51 antidepressant efficacy 51 antihypertensive drugs 51 paricalcitol 51 Cochrane Collaboration 51 bivariate analyzes 51 CHARISMA trial 51 double blind placebo 51 PLoS Genetics 51 rofecoxib 51 nomograms 51 Clinical Outcomes Utilizing Revascularization 51 Swedish Mammography Cohort 51 Acquired Immune Deficiency Syndromes 51 susceptibility loci 51 journal Diabetologia 51 CYP#D# inhibitor 51 carotid atherosclerosis 51 pharmacologic treatments 50 prospective randomized placebo 50 viral kinetic 50 Winkelmayer 50 aldosterone antagonists 50 rs# [001] 50 ELCAP 50 SYNTAX trial 50 dietary patterns 50 venous thrombosis 50 myocardial ischemia 50 #:#-# [028] 50 pioglitazone Actos 50 inverse association 50 logistic regression model 50 actigraphy 50 lipid levels 50 Comparative Physiology 50 Nature Genetics 50 nonfasting 50 active comparator 50 confounder 50 CYPHER Stent 50 salmeterol 50 neoadjuvant 50 contralateral breast cancer 50 journal Neurosurgery 50 Doxil ® 50 Atherosclerosis Risk 50 HIV HCV coinfected 50 familial aggregation 50 preoperative chemotherapy 50 serum uric acid 50 multicenter phase 50 journal Behavioral Neuroscience 50 ticagrelor 50 ARCOXIA 50 convergent validity 50 teriflunomide 50 journal Epilepsia 50 Systematic reviews 50 SLN biopsy 50 statins cholesterol lowering 50 journal Arteriosclerosis Thrombosis 50 telmisartan 50 routine episiotomy 50 HMG CoA reductase inhibitors 50 BoNTA 50 Psychosomatic Research 50 journal Critical Care 50 cardio protective 50 ischemic cardiomyopathy 50 nulliparous women 50 Logistic regression 50 commonly prescribed antidepressants 50 multivariate logistic regression 50 antihypertensive therapy 50 journal Thorax 50 dietary antioxidants 50 Histopathological 50 prostate cancer CaP 50 NSABP B 50 multicenter prospective 50 CARDIA study 50 celecoxib 50 clinically meaningful differences 50 journal Pharmacotherapy 50 Buijsse 50 magnesium intake 50 Investigative Dermatology 50 DAPT 50 Clinical Psychopharmacology 50 pioglitazone 50 HDL cholesterol 50 Celecoxib APC trial 50 Cochrane Database Syst Rev 50 Sequenced Treatment Alternatives 50 gene variants 50 Karolinska Institute Stockholm 50 tricyclic antidepressants 50 adiponectin levels 50 accompanying editorial 50 lowering LDL cholesterol 50 HCV RESPOND 2 50 journal Neuropsychopharmacology 50 authors conclude 50 Cancer Epidemiology Biomarkers 50 lymphadenectomy 50 BERKELEY CA UroToday.com 50 Lp PLA 2 50 Ann Intern Med 50 oncologic outcomes 50 dose aspirin 50 logistic regression models 50 bmj.com 50 KIF6 gene variant 50 TAXUS VI 50 Geriatric Society 50 oral rivaroxaban 50 mycophenolate mofetil 50 HIVNET 50 lipid profiles 50 Study AREDS 50 probiotic supplementation 50 EEG abnormalities 50 thromboprophylaxis 50 Bivalirudin 50 GnRH agonists 50 longitudinal observational study 50 Randomized Study 50 bmj.com today 50 International Neuropsychological Society 50 Relieve Depression 50 EuroIntervention 50 prognostic significance 50 methodological limitations 50 flavonoid intake 50 Bonferroni correction 50 genotypic 50 antiplatelet drugs 50 coronary heart 50 ISAR REACT 50 multivariate analysis 50 venous thromboembolic disease 50 blind randomized controlled 50 BCIRG 50 everolimus eluting stents 50 rosiglitazone Avandia 50 HRQOL 50 neurodevelopmental outcome 50 secretin 50 et al SEE ARTICLE 50 multivariate Cox 50 journal Oncogene 50 Trial ASCOT 50 psychodynamic therapy 50 Mayo Clinic oncologist 50 J Clin Endocrinol Metab 50 Gøtzsche 50 conjugated equine estrogen 50 journal Paediatrics 50 pharmacokinetics PK 50 Behavioral Scientist 50 Complications Trial 50 serum lipids 50 Phytotherapy Research 50 AJCN 50 MEDLINE 50 journal Carcinogenesis 50 platelet activation 50 multivariable analysis 50 aspirin clopidogrel 50 Clinical Nutrition vol 50 placebo controlled Phase 50 PERSEUS 50 computed tomography CT angiography 50 Multivariate logistic regression 50 symptomatic VTE 50 gallstone disease 50 premenopausal women 50 ACTIVE W 50 oophorectomy 50 postmarketing surveillance 50 statin drugs 50 biological plausibility 49 Poisson regression 49 postmenopausal 49 NHANES #-# 49 placebo controlled randomized 49 intraobserver 49 Environ Health Perspect 49 multicenter Phase II 49 NEJM editorial 49 CHAMPION PCI 49 Clinical Psychology Review 49 multicenter clinical 49 genetic locus 49 ezetimibe 49 ERSPC 49 Sackner Bernstein 49 MGd 49 subclinical hypothyroidism 49 dietary calcium intake 49 adjuvant therapy 49 Autism Consortium 49 TAXUS ARRIVE 49 Psychopharmacology 49 IMPROVE IT 49 unmeasured confounders 49 Cardiol 49 postprandial glycemia 49 journal CHEST 49 hip BMD 49 Oreopoulos 49 intravenous bisphosphonates 49 Millennium Cohort Study 49 variance ANOVA 49 Cardiovascular Risk 49 Dietary intake 49 LUX Lung 49 spontaneous preterm delivery 49 telomere lengths 49 PRIMO CABG2 49 BJU Int 49 predictive validity 49 Multicenter AIDS 49 Slone Epidemiology Center 49 NEVO RES 49 chemoradiation 49 journal Diabetes 49 MTWA testing 49 QoL 49 anti arrhythmic drug 49 journal PloS 49 peer reviewed 49 STICH trial 49 methodological flaws 49 randomized multicentre 49 singleton pregnancies 49 adenotonsillectomy 49 prespecified 49 BRIM3 49 Neuroepidemiology 49 fructose intake 49 journal PLoS Genetics 49 N Engl J 49 sulphonylureas 49 HNSCC 49 Annals 49 soy isoflavones 49 Study HERS 49 Framingham Offspring 49 TAXUS ATLAS 49 journal Lancet 49 Arteriosclerosis Thrombosis 49 abnormal glucose tolerance 49 Randomized Controlled Trials 49 resected pancreatic cancer 49 intracranial stenosis 49 tolvaptan 49 postmenopausal osteoporotic women 49 J Am Coll 49 causal inference 49 carotid IMT 49 Symptom Management 49 pharmacological interventions 49 fasting glucose levels 49 GFT# 49 Epilepsia 49 hsCRP 49 Glucosamine chondroitin Arthritis 49 N. Engl 49 ACC AHA 49 journal Psychopharmacology 49 sorafenib Nexavar 49 journal Evolutionary Psychology 49 MDRD 49 Ann Oncol 49 Psychoneuroendocrinology 49 Hashibe 49 teriparatide 49 DHEA supplementation 49 psychometric properties 49 dobutamine stress 49 pyridostigmine 49 confounding variables 49 ASTEROID 49 Ovarian PLCO Cancer 49 radiographic outcomes 49 #:#-# [035] 49 Neuropsychopharmacology 49 Neurochemistry 49 biologically plausible 49 apolipoproteins 49 PROSTVAC TM 49 aprotinin 49 WHEL 49 olaparib 49 Hilakivi Clarke 49 Psychosomatics 49 RTOG 49 paroxysmal AF 49 noninferiority 49 paroxetine Paxil 49 dietary acrylamide 49 MADIT CRT 49 antiarrhythmic 49 Nutrition EPIC 49 thromboembolic 49 hippocampal volume 49 NATRECOR ® 49 ROCKET AF 49 elevated LDL cholesterol 49 SSRIs 49 Cardiorespiratory fitness 49 biologic plausibility 49 reanalysis 49 DASH diet 49 journal Ambulatory Pediatrics 49 HbA 1c 49 Psychological Medicine 49 myocardial uptake 49 coinfected patients 49 Rosuvastatin 49 gadobutrol 49 overdiagnosis 49 REALITY Trial 49 journal Obstetrics 49 Stacy Tessler Lindau 49 randomized multicenter Phase III 49 venous thromboembolisms 49 journal Hormones 49 Multivariate analysis 49 EORTC 49 Br J Cancer 49 tiotropium 49 NCCAM 49 HealthCore 49 Myocardial Infarction Study 49 Controlled Trial 49 phase IIb trial 49 tamsulosin 49 Physiology Regulatory Integrative 49 mg BID dose 49 Attack Trial ALLHAT 49 USA UroToday.com 49 interobserver reliability 49 Nature Reviews Neuroscience 49 borderline statistical significance 49 Randomized Controlled Trial 49 eptifibatide 49 patients undergoing CABG 49 AVOREN 49 NHANES surveys 49 prespecified secondary 49 retrospective observational 49 Epidemiologic studies 49 tHcy 49 vegetable intake 49 serum GGT 49 phylogenetic analysis 49 Candesartan 49 Nutrition Examination Survey NHANES 49 journal SLEEP 49 preoperative MRI 49 fluoxetine Prozac 49 gene expression profiles 49 plasma pharmacokinetics 49 Experimental Psychology General 49 pelvic lymphadenectomy 49 postoperative radiotherapy 49 CrossRef Medline 49 Neurology Neurosurgery 49 Human Molecular Genetics 49 infliximab Remicade 49 CLBP 49 prospectively randomized 49 CLARITY study 49 cardioembolic stroke 49 journal Human Reproduction 49 calcium intake 49 beta carotene supplements 49 CVD mortality 49 liver biopsies 49 viral kinetics 49 microarray experiments 49 rFVIIa 49 JoAnn Manson 49 prognostic factors 49 CLA supplementation 49 PRECiSE 49 Kivipelto 49 guggul 49 urodynamic studies 49 EMBO Molecular Medicine 49 polyarticular 49 adjuvant therapies 49 pravastatin therapy 49 ABCSG 49 stone formers 49 Boffetta 49 lowering homocysteine 49 CTEPH 49 lipid lowering agents 49 antibiotic prophylaxis 49 Therapeutic Advances 49 PNAS 49 PLOS 49 KRAS status 49 Bresalier 49 Statistical analyzes 49 J Nutr 49 nonparametric 49 CAPRIE 49 chlorthalidone 48 lipid lowering medications 48 nephron sparing surgery 48 logistic regression 48 Leitzmann 48 Antihypertensive 48 spinal manipulation 48 nonvertebral fractures 48 Dr. Pasinetti 48 number NCT# ClinicalTrials.gov 48 Epidemiology 48 #:# -# [004] 48 adjuvant chemotherapy 48 XZK 48 Milbank Quarterly 48 ischemic cardiovascular 48 NCT# ClinicalTrials.gov 48 study1 48 atherosclerotic vascular disease 48 ANOVA 48 SpHb monitoring 48 journal Behavioral Ecology 48 elevated triglycerides 48 serum vitamin D 48 myocardial infarction MI 48 endometrial carcinoma 48 vitamin D inadequacy 48 prostate cancer PCa 48 Avandia Actos 48 perinatal outcomes 48 eplerenone 48 conjugated estrogen 48 somatoform disorders 48 Lancet Oncology journal 48 IJCP 48 acamprosate 48 Pharmacological Research 48 Fulvestrant 48 sildenafil Viagra 48 syndromal 48 Outcomes Research 48 clinico pathological 48 National Epidemiologic Survey 48 PLoS Computational Biology 48 undergoing coronary angiography 48 thrombophilia 48 landmark ATHENA 48 pp #-# 48 Early Childhood Longitudinal Study 48 Am J Pathol 48 chemoradiotherapy 48 ABCB1 48 prospective randomized multicenter 48 KIF6 carriers 48 irbesartan 48 conventional angiography 48 MADIT 48 KLRI 48 Polyp Prevention Trial 48 Braunwald 48 HORIZONS AMI 48 ADVANCE PD 48 desvenlafaxine succinate 48 gene polymorphisms 48 APOE genotype 48 dose statin therapy 48 #:#-# [023] 48 lipid abnormalities 48 GISSI 48 alexithymia 48 journal Arthritis 48 bazedoxifene conjugated estrogens 48 candesartan cilexetil 48 ARB telmisartan 48 hemodialysis patients 48 elevated homocysteine 48 Mayo Clinic Proceedings 48 thiazolidinediones 48 Dialysis Outcomes 48 MEND CABG 48 ClinicalTrials.gov 48 vildagliptin 48 ivabradine 48 phytoestrogens 48 clinicopathologic 48 American Geriatrics Society 48 venous thromboembolism 48 HRQL 48 muraglitazar 48 haptoglobin 48 journal Cephalalgia 48 exploratory endpoints 48 genetic determinants 48 Perforomist Inhalation Solution 48 Cancer Incidence Mortality 48 suicidality 48 Taxus Stent 48 silymarin 48 Randomised Study 48 CALERIE 48 recurrent malignant glioma 48 heritability 48 polymorphisms 48 standard chemotherapy regimen 48 See CLINICAL PHARMACOLOGY 48 psychobiological 48 Logistic regression analysis 48 prospective multicenter 48 AAPOS 48 Glucosamine Chondroitin Arthritis 48 dietary interventions 48 everolimus eluting stent 48 pregabalin 48 risperidone Risperdal 48 inhaled steroids 48 Alicja Wolk 48 Randomized 48 rs# [002] 48 SEER registry 48 EEGs 48 hypertensive patients 48 nonpharmacologic 48 cystatin C 48 urodynamic 48 neuropsychiatric symptoms 48 nabilone 48 micafungin 48 journal Developmental Psychology 48 pharmacokinetic characteristics 48 thimerosal exposure 48 recurrent venous thromboembolism 48 vitamin E 48 journal Nature Chemistry 48 Eur J Endocrinol 48 dose escalation clinical 48 Truvada tablets 48 Dr. Montori 48 ARBITER 6 48 atherogenic dyslipidemia 48 subclinical cardiovascular disease 48 NATRECOR R 48 tamoxifen raloxifene 48 journal Anesthesia 48 efficacy 48 clinical trials 48 Arthritis Rheum 48 journal Fertility 48 nondepressed 48 Socioeconomic status 48 androgen ablation 48 Xelox 48 DSMB 48 dietary supplementation 48 NIH CPSI 48 journal Nature Immunology 48 J Neurosurg 48 prognostic variables 48 corrected QT interval 48 EBUS FNA 48 Radiation Therapy Oncology 48 JNCI 48 Circulation Cardiovascular Quality 48 fibrate 48 CaPSURE 48 Cleft Palate Craniofacial 48 scintigraphic 48 cardioprotective effect 48 Dabigatran 48 THE LANCET 48 Tumor Response 48 SF #v# 48 serum lipid levels 48 Comorbidity 48 hemoglobin A1c levels 48 hydroxychloroquine 48 dietary folate intake